Centre Hospitalier Universitaire De Bordeaux

Oncology and Hematologic Malignancies

The sponsor is active in gastrointestinal oncology, with studies in rectal cancer, gastric adenocarcinoma, pancreatic cancer, and bile duct cancer. Its oncology portfolio also includes gastroenteropancreatic neuroendocrine tumours, metastatic renal cell carcinoma, refractory solid tumours, and FLT3-mutated acute myeloid leukemia.

  • Rectal cancer and locally recurrent rectal cancer
  • Pancreatic and biliary tract cancers
  • Gastric cancer and neuroendocrine tumours
  • Metastatic renal cell carcinoma and solid tumours
  • Acute myeloid leukemia

Research in this area includes imaging for tumour staging, treatment selection in advanced disease, and strategies for difficult-to-treat malignant conditions.

Neurology and Cerebrovascular Disease

The clinical programme covers stroke recovery and acute management, including studies of functional outcome, secondary brain injury, and post-stroke neuropsychiatric symptoms. It also includes work on apathy after stroke and interventions for intracranial surgery patients.

  • Acute ischemic stroke
  • Post-stroke apathy
  • Secondary degeneration after stroke
  • Supratentorial intracranial surgery
  • Neurological deterioration in the acute phase

The sponsor also investigates diagnostic imaging and symptom-targeted approaches linked to cerebrovascular injury and neurological complications.

Autoimmune, Inflammatory, and Dermatologic Disorders

Multiple studies address rheumatoid arthritis, vitiligo, systemic sclerosis, and Raynaud phenomenon, reflecting a strong interest in immune-mediated disease. The portfolio also includes immune-modulating approaches in mental disorder with proven autoimmunity.

  • Rheumatoid arthritis
  • Vitiligo
  • Systemic sclerosis
  • Raynaud phenomenon
  • Autoimmune-associated psychiatric symptoms

These trials span joint disease, skin depigmentation, vascular autoimmunity, and immune-related neuropsychiatric presentations.

Cardiovascular, Thrombotic, and Infective Conditions

The sponsor studies atrial fibrillation, left atrial appendage closure, and antithrombotic strategies related to stroke prevention. It also conducts research in prosthetic valve infective endocarditis and prosthetic joint infection, combining cardiovascular and infection-focused clinical interests.

  • Atrial fibrillation and atrial appendage management
  • Anticoagulant and antiplatelet strategies
  • Prosthetic valve infective endocarditis
  • Prosthetic joint infection
  • Stroke prevention after cardiac procedures

Its research also extends to peri-procedural cerebral imaging and infection diagnosis in implanted or prosthetic settings.

Urology, Obstetrics, Infectious Diseases, and Perioperative Care

Additional studies focus on posterior urethral valves, postpartum hemorrhage, human immunodeficiency virus, and asymptomatic anal LGV infection. The sponsor also evaluates perioperative pain control and airway management in surgical and emergency settings.

  • Posterior urethral valves and bladder dysfunction
  • Postpartum hemorrhage
  • HIV-related immune response
  • Asymptomatic anal LGV infection
  • Emergency and postoperative procedural care

These investigations include paediatric urology, maternal bleeding, chronic viral infection, and infection treatment in sexually transmitted disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Norepinephrine for Improving Outcomes in Patients with Acute Progressive Stroke

    Recruiting

    3 1 1 1
    Investigated drugs:
    France
  • Study on Rituximab for Patients with Mental Disorders and Autoimmunity

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Doxycycline for Asymptomatic Anal LGV Infection in Patients with Asymptomatic Anal LGV Infection

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    France
  • Venetoclax Added to Standard Chemotherapy and Midostaurin for Patients with FLT3-Mutated Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • 68Ga-FAPI-46 PET-CT for Initial Staging of Gastric Cancer in Patients Eligible for Curative Treatment

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study of botulinum toxin type A injections to prevent scarring in patients after heart surgery with sternotomy

    Not yet recruiting

    3 1 1
    France